Mood Stabiliser Therapy

Mood stabiliser therapy uses medications such as lithium, valproate or lamotrigine to even out extreme mood fluctuations and prevent manic or depressive episodes in bipolar and related mood disorders. Because these medications have a narrow therapeutic range and potential for organ toxicity, treatment requires careful dose titration and regular blood monitoring. The psychiatrist selects a specific agent based on the pattern of the patient's mood episodes and their overall medical history. Long-term maintenance treatment is usually necessary to prevent relapse, as stopping medication prematurely significantly raises the risk of future episodes.

Mood Stabiliser Therapy is recommended for patients diagnosed with specific conditions where other approaches have been insufficient. Your Psychiatry specialist will assess your suitability based on your diagnosis, health history, and treatment goals.

The typical duration is Long-term, often ongoing maintenance treatment. This may vary based on the complexity of your case and individual response to treatment.

Recovery typically takes Mood stabilization is typically seen over several weeks of treatment. Periodic blood tests are required to monitor drug levels and organ function, treatment is usually continued long-term to prevent relapse, and dose adjustments are made based on regular psychiatric review.. Your care team will provide specific instructions based on your response and overall health.

Side effects vary by individual and are detailed in the section above. Your specialist will discuss all risks and benefits with you before treatment begins. Serious adverse effects are uncommon but are part of the informed consent process.

Mood Stabiliser Therapy has a documented success rate of 70-80% reduction in mood episode frequency at accredited facilities. Outcomes depend on disease stage, patient health, and adherence to the treatment plan and aftercare instructions.